Haffkine Bio Pharmaceutical Corporation Limited

Haffkine Bio Pharmaceutical Corporation Limited has published Corrigendum - Supply Of Hemophilia And Thalassemia Medicine Phase I / 2019-20 , Name Of The Item : , Ivig 2 . 5% ( 2 . 5 Gm / 100 Ml ) , Ivig 5 % ( 5 Gm / 100 Ml ) , Ivig 10 % ( 10 Gm / 100 Ml ) , Tab Deferasirox 250 Mg , Tab Deferasirox 500 Mg , Tab . Deferiprone 250 Mg , Tab . Deferiprone 500 Mg , Inj . Desferal 500 Mg , Tab . Hydroxyurea 500 Mg , Factor Vii- 1 Mg { Recombinant Factor Vii A } , Factor Ix- 600 Iu { Plasma Derived Factor - Ix } , Apcc { Activate Prothrombin Complex Concentrate } / Feiba 500 Iu. Last date of submission for this tender is 2020-01-14. This is a Medicine tender in Hbpcl, Acharya Donde Marg, Parel, Mumbai-400012, Maharashtra